AA
JAZZ icon

Ancora Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ancora Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.2K Buy
160
+7
+5% +$1.22K ﹤0.01% 1351
2025
Q4 		$26K Buy
153
+119
+350% +$18.2K ﹤0.01% 1428
2025
Q3 		$4.48K Hold
34
– – ﹤0.01% 1519
2025
Q2 		$3.61K Hold
34
– – ﹤0.01% 1542
2025
Q1 		$4.22K Hold
34
– – ﹤0.01% 1451
2024
Q4 		$4.19K Hold
34
– – ﹤0.01% 1490
2024
Q3 		$3.79K Hold
34
– – ﹤0.01% 1485
2024
Q2 		$3.63K Hold
34
– – ﹤0.01% 1493
2024
Q1 		$4.09K Buy
+34
New +$4.17K ﹤0.01% 1474
2023
Q4 		– Sell
-55
Closed -$7.12K – 1798
2023
Q3 		$7.12K Hold
55
– – ﹤0.01% 1347
2023
Q2 		$6.82K Hold
55
– – ﹤0.01% 1336
2023
Q1 		$8.05K Hold
55
– – ﹤0.01% 1322
2022
Q4 		$9K Sell
55
-75
-58% -$11K ﹤0.01% 1362
2022
Q3 		$17K Sell
130
-13
-9% -$1.98K ﹤0.01% 1380
2022
Q2 		$22K Buy
143
+13
+10% +$2K ﹤0.01% 1409
2022
Q1 		$20K Hold
130
– – ﹤0.01% 1550
2021
Q4 		$17K Hold
130
– – ﹤0.01% 1638
2021
Q3 		$17K Buy
130
+104
+400% +$15.7K ﹤0.01% 1530
2021
Q2 		$5K Buy
+26
New +$4.5K ﹤0.01% 1700

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ancora Advisors's JAZZ Position: Q1 2026 in Review

Ancora Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 4.6% in Q1 2026, buying an estimated $1.22K and bringing the position to 160 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Ancora Advisors first reported a position in JAZZ in Q2 2021 and has held it in 19 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Ancora Advisors held 160 shares of Jazz Pharmaceuticals worth $30.2K as of Q1 2026.
  • Ancora Advisors bought 7 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.22K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1351 holding.
  • Ancora Advisors first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.